Regarding the genetic mutations that are known to increase the risk of developing BC, the European Society of Breast Cancer Specialists (EUSOMA) estimates that 3% of all BC cases are caused by an underlying deleterious mutation of the BRCA1 or BRCA2 genes [12]. This evidence concerns the gene BRCA1 and breast cancer.